JAC Advance Access originally published online on May 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy 2004 54(1):240-242; doi:10.1093/jac/dkh270
JAC vol.54 no.1 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
Nitroimidazole resistance genes (nimB) in anaerobic Gram-positive cocci (previously Peptostreptococcus spp.)
1 Department of Medical Microbiology (G4), Faculty of Health Sciences, University of the Free State, Bloemfontein; 2 Medical Research Council, Cape Town, South Africa
* Corresponding author. Tel: +27-51-4053648; Fax: +27-51-4443437; Email: gnmbml.md{at}mail.uovs.ac.za
Objectives: To investigate metronidazole resistance and the prevalence of nitroimidazole (nim) genes in clinically isolated anaerobic Gram-positive cocci.
Methods: Metronidazole susceptibility was determined in 99 strains of anaerobic Gram-positive cocci and PCR amplification for the nim gene carried out on 61 strains (metronidazole MIC
0.5 mg/L).
Results: The nimB gene was detected in 34% (21/61) of the strains. These included two highly resistant Finegoldia magna strains (MICs >128 mg/L). The nimB gene was, however, also demonstrated in 90% (19/21) of susceptible strains.
Conclusions: Although the nimB gene may be implicated in the high-level metronidazole resistance in 2 F. magna strains, the alarmingly high prevalence of the nimB gene in anaerobic Gram-positive cocci cannot be directly associated with resistance and the possibility of a silent nimB gene should be considered.
Keywords: anaerobic Gram-positive cocci , metronidazole resistance , nim genes
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Heller, L. Kellenberger, and S. Shapiro Antipropionibacterial Activity of BAL19403, a Novel Macrolide Antibiotic Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1956 - 1961. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kononen, A. Bryk, P. Niemi, and A. Kanervo-Nordstrom Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described Peptostreptococcus stomatis Isolated from Various Human Sources Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2205 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. RANI, R.S. MURTHY, S. BHATTACHARYA, V. AHUJA, M.A. RIZVI, and J. PAUL CHANGES IN BACTERIAL PROFILE DURING AMEBIASIS: DEMONSTRATION OF ANAEROBIC BACTERIA IN ALA PUS SAMPLES Am J Trop Med Hyg, November 1, 2006; 75(5): 880 - 885. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Soki, M. Gal, J. S. Brazier, V. O. Rotimi, E. Urban, E. Nagy, and B. I. Duerden Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains J. Antimicrob. Chemother., February 1, 2006; 57(2): 212 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mory, J.-P. Carlier, C. Alauzet, M. Thouvenin, H. Schuhmacher, and A. Lozniewski Bacteremia Caused by a Metronidazole-Resistant Prevotella sp. Strain J. Clin. Microbiol., October 1, 2005; 43(10): 5380 - 5383. [Abstract] [Full Text] [PDF] |
||||



